SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-015549
Filing Date
2020-04-06
Accepted
2020-04-06 17:06:52
Documents
4
Period of Report
2020-05-22
Effectiveness Date
2020-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A chrs-def14a_20200522.htm DEF 14A 932338
2 GRAPHIC gtpevkjnies2000003.jpg GRAPHIC 49327
3 GRAPHIC gtpevkjnies2000002.jpg GRAPHIC 49325
4 GRAPHIC gtpevkjnies2000001.jpg GRAPHIC 3494
  Complete submission text file 0001564590-20-015549.txt   1074650
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36721 | Film No.: 20777667
SIC: 2836 Biological Products, (No Diagnostic Substances)